atropine has been researched along with levodopa in 43 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 17,774 | 1,900 | 4,946 |
| Protein | Taxonomy | atropine (IC50) | levodopa (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (69.77) | 18.7374 |
| 1990's | 3 (6.98) | 18.2507 |
| 2000's | 6 (13.95) | 29.6817 |
| 2010's | 4 (9.30) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Hosoya, E; Oka, T | 1 |
| Fuenmayor, LD; Vogt, M | 1 |
| Arnon, N; Cohen, H; LeRoith, D; Spitz, IM; Trestian, S | 1 |
| Battista, AF; Goldstein, M; Miyamoto, T | 1 |
| Carolei, A; Margotta, V; Palladini, G | 1 |
| Furuta, Y; Hashimoto, K; Washizaki, M | 1 |
| Bogaert, MG; Willems, JL | 1 |
| Gateau, G; Meinel, R; Strudel, G | 1 |
| Shchedrunov, VV | 1 |
| De Ryck, M; Ramirez, VD; Schallert, T; Teitelbaum, P; Whishaw, IQ | 1 |
| Ishikawa, T; Yamamoto, M | 1 |
| Bevan, P; Bradshaw, CM; Szabadi, E | 1 |
| Bermanzohn, PC; Lipper, S | 1 |
| Cotzias, GC; Dahl, K; Finn, BW; Mendez, JS | 1 |
| Algeri, S; Bonollo, L; Buniva, G; Cerletti, C; Curcio, M; Minazzi, M; Minoli, G; Morselli, PL | 1 |
| Antonaccio, MJ; Kerwin, L | 1 |
| Bianchi, R; Bircher, B; Duss, I; Fisch, HU; Groner, M; Groner, R; Hofer, D; Koelbing, U; Walder, F | 1 |
| Onodera, K; Shinoda, H | 1 |
| Lucas, TS; Quock, RM | 1 |
| Maayan, ML; Sellitto, RV; Volpert, EM | 1 |
| Fedchenko, IuG; Oparin, AG | 1 |
| Poddar, MK; Ray, SK | 1 |
| Dement, WC; Guilleminault, C; Wilson, RA | 1 |
| Antonaccio, MJ; Burrell, R; Robson, RD | 1 |
| Boggan, WO; Schlesinger, K | 1 |
| Lauschke, HP; Thieme, F | 1 |
| Ghosh, MN; Gopalakrishnan, V; Pillai, NP; Ramaswamy, S | 1 |
| Lundquist, I | 1 |
| Pappas, BA; Robinson, TE; Vanderwolf, CH | 1 |
| Pilc, A; Rogóz, Z; Skuza, G | 1 |
| Hjälmås, K; Rubenson, A; Sillén, U | 1 |
| Caviglia, A; Cellitti, M; Di Bianco, V; Di Castro, A; Pavoncello, S | 1 |
| Bédard, PJ; Gomez-Mancilla, B | 1 |
| Chung, SJ; Lee, HT; Seo, EK; Shim, CK | 1 |
| Ashby, R; Karouta, C; Kelly, T; Morgan, I; Thomson, K | 1 |
1 trial(s) available for atropine and levodopa
| Article | Year |
|---|---|
Specific effects of the benzodiazepine midazolam on visual receptive fields in light and dark adapted human subjects.
Topics: Adaptation, Ocular; Adult; Atropine; Dark Adaptation; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Midazolam; Photic Stimulation; Sulpiride; Visual Fields | 1992 |
42 other study(ies) available for atropine and levodopa
| Article | Year |
|---|---|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of humoral modulators and naloxone on morphine-induced changes in the spontaneous locomotor activity of the rat.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Fenclonine; Levodopa; Male; Methyltyrosines; Morphine; Motor Activity; Naloxone; Neurotransmitter Agents; Rats; Scopolamine | 1976 |
The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics.
Topics: Animals; Antipsychotic Agents; Atropine; Biogenic Amines; Brain Chemistry; Catalepsy; Humans; Levodopa; Male; Mice; Parasympatholytics; Parasympathomimetics; Rats; Serotonin; Time Factors | 1979 |
Failure of metoclopramide to influence LH, FSH and TSH secretion or their responses to releasing hormones.
Topics: Adolescent; Adult; Atropine; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Levodopa; Luteinizing Hormone; Male; Metoclopramide; Pituitary Hormone-Releasing Hormones; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1979 |
Modification of involuntary movements by centrally acting drugs.
Topics: Aminooxyacetic Acid; Animals; Atropine; Bicuculline; Bromocriptine; Dopamine; Haloperidol; Haplorhini; Levodopa; Movement Disorders; Physostigmine; Picrotoxin; Piperazines; Piribedil; Receptors, Drug; Synaptic Transmission; Thalamic Nuclei; Theophylline | 1975 |
Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Benserazide; Bromocriptine; Central Nervous System; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Levodopa; Models, Neurological; Motor Activity; Physostigmine; Piribedil; Planarians; Reserpine; Synaptic Transmission; Turbellaria | 1975 |
beta-Adrenoceptor stimulation of exocrine secretion from the rat pancreas.
Topics: Acetylcholine; Animals; Atropine; Catecholamines; Dopamine; Haloperidol; Isoproterenol; Levodopa; Male; Myocardial Contraction; Pancreas; Phenoxybenzamine; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Secretin; Spinal Cord; Sympathomimetics; Vagotomy | 1978 |
Dopamine-induced neurogenic vasodilatation in isolated perfused muscle preparation of the dog.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Animals; Apomorphine; Atropine; Autonomic Fibers, Preganglionic; Blood Vessels; Diphenhydramine; Dogs; Dopamine; Dopamine Antagonists; Female; Ganglia, Autonomic; Haloperidol; Hindlimb; Histamine; In Vitro Techniques; Levodopa; Male; Muscles; Perfusion; Phentolamine; Reflex; Sympathetic Nervous System; Vascular Resistance | 1975 |
[Fluorogenic amines in the notochords of chick embryos treated by cholinergics].
Topics: Animals; Atropine; Biogenic Amines; Carbachol; Chick Embryo; Levodopa; Microscopy, Fluorescence; Nicotine; Norepinephrine; Parasympathomimetics; Propranolol; Reserpine; Spine | 1977 |
[Evaluation of therapeutic methods used in stomach ulcer according to data obtained by prolonged endoscopic control].
Topics: Adult; Aged; Atropine; Endoscopy; Evaluation Studies as Topic; Humans; Levodopa; Middle Aged; Oxyphenonium; Procainamide; Stomach Ulcer | 1977 |
Excessive bracing reactions and their control by atropine and L-DOPA in an animal analog of Parkinsonism.
Topics: Animals; Atropine; Brain; Disease Models, Animal; Dopamine; Forelimb; Hydroxydopamines; Levodopa; Locomotion; Male; Norepinephrine; Parkinson Disease, Secondary; Postural Balance; Rats | 1979 |
Involvement of the cholinergic mechanism in depression of the caudate spindle.
Topics: Animals; Atropine; Cats; Caudate Nucleus; Depression, Chemical; Female; Levodopa; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Physostigmine; Reticular Formation | 1979 |
The action of microelectrophoretically applied L-3,4-dihydroxyphenylalanine (DOPA) on single cortical neurones.
Topics: Acetylcholine; Action Potentials; Animals; Atropine; Cats; Cerebral Cortex; Electrophoresis; Female; Levodopa; Male; Microchemistry; Neurons; Norepinephrine; Phentolamine; Propranolol; Rats; Time Factors | 1976 |
Letter: Electroconvulsive therapy in patients with parkinsonism.
Topics: Amantadine; Atropine; Depression; Diphenhydramine; Electroconvulsive Therapy; Female; Humans; Levodopa; Methohexital; Middle Aged; Parkinson Disease; Succinylcholine; Suicide | 1975 |
Rotatory behavior induced in nigra-lesioned rats by N-propylnoraporphine, apomorphine, and levodopa.
Topics: Animals; Apomorphine; Aporphines; Atropine; Behavior, Animal; Brain Injuries; Carbidopa; Dose-Response Relationship, Drug; Drug Synergism; Hydroxydopamines; Levodopa; Male; Rats; Rotation; Substantia Nigra; Time Factors | 1975 |
Effect of anticholinergic drugs on gastro-intestinal absorption of L-dopa in rats and in man.
Topics: Administration, Oral; Adult; Aged; Animals; Atropine; Digestive System; Drug Interactions; Female; Humans; Injections, Intraperitoneal; Intestinal Absorption; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Rats; Time Factors; Trihexyphenidyl | 1976 |
Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
Topics: Animals; Atropine; Benserazide; Blood Pressure; Carbidopa; Dogs; Dopamine; Drug Interactions; Female; Levodopa; Male; Monoamine Oxidase Inhibitors; Norepinephrine; Phentolamine; Pressoreceptors; Propranolol; Vagus Nerve | 1976 |
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl | 1991 |
A selective potentiation by naloxone of L-dopa but not atropine suppression of oxotremorine-induced tremor in mice.
Topics: Animals; Atropine; Drug Synergism; Levodopa; Male; Mice; Mice, Inbred ICR; Naloxone; Oxotremorine; Time Factors; Tremor | 1985 |
Dopamine and L-dopa: inhibition of thyrotropin-stimulated thyroidal thyroxine release.
Topics: Adrenergic alpha-Antagonists; Animals; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Atropine; Bucladesine; Carbidopa; Cyclic AMP; Dopamine; Dopamine beta-Hydroxylase; Female; Levodopa; Mice; Receptors, Adrenergic, alpha; Receptors, Dopamine; Sulpiride; Thyroid Gland; Thyrotropin; Thyroxine | 1986 |
[Effect of neurotropic drugs on the course of peptic ulcer].
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Atropine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Peptic Ulcer | 1987 |
Central cholinergic-dopaminergic interaction in carbaryl-induced tremor.
Topics: Animals; Atropine; Carbaryl; Carbidopa; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Levodopa; Male; Rats; Receptors, Cholinergic; Receptors, Dopamine; Tremor | 1985 |
A study on cataplexy.
Topics: 5-Hydroxytryptophan; Adult; Atropine; Cataplexy; Electroencephalography; Electromyography; Electrooculography; Female; Humans; Levodopa; Male; Middle Aged; Narcolepsy; Reflex, Abnormal; Reflex, Monosynaptic; Reflex, Stretch; Sleep, REM | 1974 |
The effects of L-dopa and alpha-methyldopa on reflexes and sympathetic nerve function.
Topics: Animals; Atropine; Barbiturates; Benserazide; Blood Pressure; Carbidopa; Carotid Arteries; Dogs; Electric Stimulation; Heart Rate; Hindlimb; Levodopa; Methyldopa; Monoamine Oxidase Inhibitors; Neurons; Perfusion; Posture; Reflex; Regional Blood Flow; Sympathetic Nervous System; Vagotomy; Vagus Nerve | 1974 |
Pharmacological correlates of ECS induced disruption of a passive avoidance task in mice.
Topics: 5-Hydroxytryptophan; Acetates; Animals; Atropine; Avoidance Learning; Electroshock; Female; Levodopa; Male; Memory; Mice; Mice, Inbred C57BL; Physostigmine; Reaction Time; Reserpine; Seizures; Thiosemicarbazones | 1974 |
[Parkinson disease].
Topics: Atropine; Automobile Driving; Biogenic Amines; Diagnosis, Differential; Disability Evaluation; Extrapyramidal Tracts; Humans; Levodopa; Neurotransmitter Agents; Parkinson Disease; Physical Therapy Modalities; Substantia Nigra | 1981 |
Effect of cholinergic agonists and antagonists on jumping behaviour induced by morphine and L-dopa in mice.
Topics: Animals; Atropine; Atropine Derivatives; Levodopa; Male; Mice; Morphine; Motor Activity; Neostigmine; Parasympatholytics; Parasympathomimetics; Physostigmine | 1984 |
Cholinergic muscarinic effects on insulin release in mice.
Topics: Animals; Atropine; Blood Glucose; Carbachol; Dopamine; Dose-Response Relationship, Drug; Female; Glucan 1,4-alpha-Glucosidase; Glucosidases; Insulin; Insulin Secretion; Islets of Langerhans; Levodopa; Mice; Parasympathetic Nervous System | 1982 |
Monoamine replacement after reserpine: catecholaminergic agonists restore motor activity but phenylethylamine restores atropine-resistant neocortical low voltage fast activity.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Atropine; Cerebral Cortex; Clonidine; Dextroamphetamine; Evoked Potentials; Levodopa; Lysergic Acid Diethylamide; Motor Activity; Phenethylamines; Rats; Receptors, Cholinergic; Reserpine | 1980 |
Histidine-induced bizarre behaviour in rats: the possible involvement of central cholinergic system.
Topics: Animals; Atropine; Behavior, Animal; Dose-Response Relationship, Drug; Histamine; Histamine Antagonists; Histidine; Levodopa; Male; Motor Activity; Parasympathetic Nervous System; Rats; Rats, Inbred Strains; Tremor | 1982 |
Central cholinergic mechanisms in L-DOPA induced hyperactive urinary bladder of the rat.
Topics: Animals; Atropine; Brain; Calcium; Hexamethonium Compounds; Levodopa; Male; N-Methylscopolamine; Oxotremorine; Phentolamine; Rats; Receptors, Adrenergic; Receptors, Cholinergic; Reserpine; Scopolamine Derivatives; Sotalol; Urinary Bladder | 1982 |
[Neurological aspects and modern trends in therapy of Parkinson's disease].
Topics: Atropine; Biperiden; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Procyclidine; Trihexyphenidyl | 1980 |
Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Atropine; Baclofen; Clonidine; Dopamine Agents; Drug Interactions; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Meperidine; Methoxydimethyltryptamines; Neurotransmitter Agents; Yohimbine | 1993 |
Effect of an aqueous extract of dried immature fruit of Poncirus trifoliata (L.) Raf. on intestinal transit in rodents with experimental gastrointestinal motility dysfunctions.
Topics: Animals; Atropine; Fruit; Gastrointestinal Motility; Levodopa; Male; Mice; Mice, Inbred ICR; Morphine; Phytotherapy; Plant Extracts; Poncirus; Rats; Rats, Sprague-Dawley | 2005 |
Effectiveness and safety of topical levodopa in a chick model of myopia.
Topics: Administration, Topical; Animals; Atropine; Chickens; Disease Models, Animal; Dopamine; Electroretinography; Eye; Humans; Intraocular Pressure; Levodopa; Mice; Myopia; Retina; Sensory Deprivation; Vision, Ocular | 2019 |